Evidence map›Paper›PMID 42846784›Full record

ReviewFrontiers in bioengineering and biotechnology2026

Bio-inks for skin regeneration: phase-adaptive design, multifunctional platforms, and 4D bioprinting frontiers.

Gita Bahrami, Aiwei Ma, Ruyi Fan, Chenggang Yi

Abstract readReview
In one paragraph

Review in Frontiers in bioengineering and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Gita Bahrami *Zhejiang University College of Medicine, Hangzhou, China.
Aiwei Ma *Zhejiang University College of Medicine, Hangzhou, China.
Ruyi FanZhejiang University College of Medicine, Hangzhou, China.
Chenggang YiZhejiang University College of Medicine, Hangzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic wounds and scarring represent major clinical challenges owing to dysregulated tissue repair processes. The emergence of 3D bioprinting offers a promising approach by enabling the fabrication of biomimetic skin substitutes that enhance chronic wound management and facilitate scar modulation. This review provides a phase-oriented framework linking bio-ink properties with the dynamic biological requirements of each wound-healing stage, integrating material engineering, regenerative mechanisms, and translational challenges with a particular focus on establishing phase-specific relationships between bioink properties and wound-healing requirements. By synthesizing recent evidence, we identify a critical gap: phase-specific bio-ink design remains largely underdeveloped and is often only implicitly considered in current analyses of healing phases. Furthermore, we highlight emerging 4D bioprinting strategies and propose that adaptive 4D bio-inks, guided by multi-omics datasets, could facilitate the development of stage-responsive systems capable of adapting therapeutic delivery to the evolving biological requirements of wound repair. Such advancements hold considerable potential to contribute to advancing chronic wound treatment and promote improved scar outcomes.

Indexed as

4D bioprintingimmunomodulationphase-specific bio-inksscar modulationskin wound healing

Identifiers

PMID42846784
PMCPMC13643387

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.